DeepAI
Log In Sign Up

Attention-Based LSTM Network for COVID-19 Clinical Trial Parsing

12/18/2020
by   Xiong Liu, et al.
0

COVID-19 clinical trial design is a critical task in developing therapeutics for the prevention and treatment of COVID-19. In this study, we apply a deep learning approach to extract eligibility criteria variables from COVID-19 trials to enable quantitative analysis of trial design and optimization. Specifically, we train attention-based bidirectional Long Short-Term Memory (Att-BiLSTM) models and use the optimal model to extract entities (i.e., variables) from the eligibility criteria of COVID-19 trials. We compare the performance of Att-BiLSTM with traditional ontology-based method. The result on a benchmark dataset shows that Att-BiLSTM outperforms the ontology model. Att-BiLSTM achieves a precision of 0.942, recall of 0.810, and F1 of 0.871, while the ontology model only achieves a precision of 0.715, recall of 0.659, and F1 of 0.686. Our analyses demonstrate that Att-BiLSTM is an effective approach for characterizing patient populations in COVID-19 clinical trials.

READ FULL TEXT
10/12/2020

Predicting Clinical Trial Results by Implicit Evidence Integration

Clinical trials provide essential guidance for practicing Evidence-Based...
11/14/2021

A Machine Learning Approach for Recruitment Prediction in Clinical Trial Design

Significant advancements have been made in recent years to optimize pati...
05/25/2021

Impact of detecting clinical trial elements in exploration of COVID-19 literature

The COVID-19 pandemic has driven ever-greater demand for tools which ena...
06/01/2021

Validating GAN-BioBERT: A Methodology For Assessing Reporting Trends In Clinical Trials

In the past decade, there has been much discussion about the issue of bi...
06/12/2020

Information Extraction of Clinical Trial Eligibility Criteria

Clinical trials predicate subject eligibility on a diversity of criteria...